Genentech Access to Care Foundation (Rituxan RA), a patient assistance program provided by Genentech, Inc., offers Rituxan at no cost for up to 90 days to those who are eligible for the program. Eligibility is based off of the following requirements: - You must be uninsured or underinsured.
Full Answer
What is the co-pay assistance program for Rituxan hycela Genentech?
Rituxan Hycela Genentech Oncology Co-pay Assistance Program: Eligible commercially insured patients may pay $5 in out-of-pocket costs for the prescribed product; annual savings of up to $25,000 per year; for additional information contact the program at 855-692-6729.
How can I get help paying for Rituxan?
Visit Genentech-Access.com/RITUXAN. Genentech offers the Genentech Oncology Co-pay Assistance Program that may help you with the out-of-pocket costs of RITUXAN.*
What is the Rituxan immunology co-pay program?
Rituxan Immunology Access Solutions can refer eligible patients to the Rituxan Immunology Co-pay Program for help with the out-of-pocket costs associated with Rituxan.* For eligible patients with commercial or public health insurance, Rituxan Immunology Access Solutions offers referrals to independent co-pay assistance foundations.†
What is Genentech access solutions for Rituxan?
Genentech Access Solutions is a program that helps people who are taking RITUXAN. Your health insurance plan and the cost of your medicine might keep you from getting your prescribed treatment. We may be able to help. To learn more about Genentech Access Solutions, call (888) 249-4918 or visit Genentech-Access.com/RITUXAN.
How do you feel after RITUXAN?
After a Rituxan (rituximab) infusion you may experience certain side effects or adverse reactions that make you feel unwell. Rituxan affects different people in different ways, but the more common side effects include: Fever (high temperature), muscle aches, headaches and chills, which are signs of infection.
What drug company makes RITUXAN?
Rituxan (Rituximab) is a monoclonal antibody indicated for treating advanced follicular lymphoma. The drug was developed by Biogen Idec and is co-promoted by Genentech, a subsidiary of Roche Group. Rituxan was approved by the US Food and Drug Administration (FDA) in 1997 for treating non-Hodgkin's lymphoma.
What is the Genentech Patient Foundation?
The Genentech Patient Foundation gives free Genentech medicine to people who don't have insurance coverage or who have financial concerns.
Are RITUXAN and rituximab the same?
RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy medicines. Adults with Chronic Lymphocytic Leukemia (CLL): with the chemotherapy medicines fludarabine and cyclophosphamide.
Will I lose my hair with rituximab?
You could lose all your hair. This includes your eyelashes, eyebrows, underarm, leg and sometimes pubic hair. Your hair will usually grow back once treatment has finished but it is likely to be softer. It may grow back a different colour or be curlier than before.
Why am I so tired after Rituxan?
Serious side effects that can occur with Rituxan include: tumor lysis syndrome (nausea, vomiting, diarrhea, and tiredness that happen due to tumor cells breaking down and releasing their contents into your blood)
What drugs does Genentech make?
Our Medicines & ProductsMedicines.Actemra® (TOCILIZUMAB [authorized for Emergency Use])Actemra® (tocilizumab)Activase® (alteplase)Alecensa® (alectinib)Avastin® (bevacizumab)Boniva Tablets® (ibandronate sodium)Cathflo Activase® (alteplase)More items...
How long can you stay on Rituxan?
Rituxan can provide up to 6 months of symptom improvement from 1 course of treatment (2 infusions given 2 weeks apart). Be sure to talk with your doctor to find out if starting and continuing treatment with Rituxan is right for you.
What are the long term side effects of Rituxan?
Does Rituxan cause any long-term side effects?Heart problems, including heart attack. Heart attacks can cause long-term problems with your heart.Kidney problems, including kidney failure.Blood cell problems, such as anemia (low levels of red blood cells) and low levels of white blood cells.
What is the success rate of rituximab?
Rituximab with bendamustine (Treanda, Cephalon) was studied in a phase 2 trial in patients with relapsed disease. This combination was found to be very effective, with an ORR of 92%.
Is there a generic version of Rituxan?
Truxima generic or biosimilar Truxima is available only as a brand-name medication. It's a type of medication called a biosimilar. A biosimilar medication is a drug that's similar to a brand-name biologic drug. Biologic drugs are made from living cells.
What is the generic of Rituxan?
Rituxan is the trade name for rituximab. In some cases, health care professionals may use the trade name rituxan when referring to the generic drug name rituximab.
What is the success rate of rituximab?
Rituximab with bendamustine (Treanda, Cephalon) was studied in a phase 2 trial in patients with relapsed disease. This combination was found to be very effective, with an ORR of 92%.
When should you not use Rituxan?
However, use of rituximab injection is not indicated in children younger than 2 years of age with GPA or MPA, in children younger than 6 months of age with mature B-cell NHL and B-AL, or in children with other conditions.
What to tell your healthcare provider before taking Rituximab?
Before receiving RITUXAN, tell your healthcare provider if you: Have had a severe reaction to RITUXAN or a rituximab product. Have a history of heart problems, irregular heartbeat, or chest pain. Have lung or kidney problems. Have had an infection, currently have an infection, or have a weakened immune system.
How long after a Rituxan infusion can you have a reaction?
Serious infusion-related reactions can happen during your infusion or within 24 hours after your infusion of RITUXAN. Your healthcare provider should give you medicines before your infusion of RITUXAN to decrease your chance of having a severe infusion-related reaction.
How to report Rituxan side effects?
Report side effects for your Rituxan prescription. Report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Get help paying for your Rituxan prescription. SUPPORT.
How long does it take for TLS to happen after Rituxan?
TLS can happen within 12 to 24 hours after an infusion of RITUXAN. Your healthcare provider may do blood tests to check you for TLS. Your healthcare provider may give you medicine to help prevent TLS.
What is Rituxan used for?
What is RITUXAN? RITUXAN is a prescription medicine used to treat adults with: Non-Hodgkin’s Lymphoma (NHL): alone or with other chemotherapy medicines. Chronic Lymphocytic Leukemia (CLL): with the chemotherapy medicines fludarabine and cyclophosphamide.
What is PML on Rituxan?
Progressive Multifocal Leukoencephalopathy (PML): PML is a rare, serious brain infection caused by a virus that can happen in people who receive RITUXAN.
How to contact Genentech?
Ask about possible side effects and any other medical questions related to your prescribed Genentech medicine. Call us at (800) 821-8590, Monday-Friday, 5am-5pm PT. Chat with us using our live chat feature, Monday-Friday, 5am-5pm PT. Email us by filling out this form. RESOURCES.
What to tell your healthcare provider before taking Rituximab?
Before receiving Rituxan, tell your healthcare provider if you: have had a severe reaction to Rituxan or a rituximab product. have a history of heart problems, irregular heartbeat, or chest pain. have lung or kidney problems. have had an infection, currently have an infection, or have a weakened immune system.
How long after Rituxan infusion can you have a reaction?
Serious infusion-related reactions can happen during your infusion or within 24 hours after your infusion of Rituxan. Your healthcare provider should give you medicines before your infusion of Rituxan to decrease your chance of having a severe infusion-related reaction.
How long after Rituxan can you use birth control?
You should use effective birth control (contraception) during treatment with Rituxan and for 12 months after your last dose of Rituxan. Talk to your healthcare provider about effective birth control.
How long after Rituxan can you give birth?
Females who are able to become pregnant should use effective birth control (contraception) during treatment with Rituxan and for 12 months after the last dose of Rituxan.
What are the symptoms of Rituxan?
Tell your healthcare provider or get medical help right away if you get any of these symptoms during or after an infusion of Rituxan: Hives (red itchy welts) or rash. Itching. Swelling of your lips, tongue, throat, or face. Sudden cough. Shortness of breath, difficulty breathing, or wheezing. Weakness.
What is TLS in cancer?
Tumor Lysis Syndrome (TLS): TLS is caused by the fast breakdown of cancer cells. TLS can cause you to have:
How to report side effects of Genentech?
Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at (800) FDA‐1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835‐2555.
What is the number to call Genentech?from genentech-access.com
Getting your prescribed medicines should not be one of them. If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683.
What is GSF patient library?from geneticsupportfoundation.org
GSF has a Patient Library that provides more background information on a variety of topics in genetics, including a genetics overview (Genetics 101), Genetics & Pregnancy, and Genetics & Cancer, among others. Learn more.
How to contact Genentech about compassionate use?from gene.com
If you are seeking information about access to one of Genentech's investigational medicines, please call Genentech's Clinical Trial Information Support Line at (888) 662-6728 or Genentech's Compassionate Use Information Line at (844) ...
Do you need to complete a patient consent form?from gene.com
Both forms are required. No action can be taken until a completed Patient Consent Form and Prescriber Service Form have been received.
Does Genentech support evrysdi?from gene.com
Please Note: At this time, Genentech supports Evrysdi, Nutropin, Cellcept, Valcyte, and Fuzeon through a separate process.
What is Genentech Access to Care Foundation?
The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.
How much does Rituxan cost?
The cost for Rituxan intravenous solution (10 mg/mL) is around $990 for a supply of 10 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
What is Rituxan used for?
Rituxan (rituximab) is a member of the antirheumatics drug class and is commonly used for Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and others.
How much does a free drug card save?
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Does Rituxan offer rebates?
Rituxan Genentech Oncology Co-pay Assistance Program Rebate: Eligible commercially insured patients enrolled in the program may be entitled to a rebate for their out-of-pocket cost if they paid the provider directly for treatment; for additional information contact the program at 855-692-6729.
What to tell your healthcare provider before taking Rituximab?
Before receiving RITUXAN, tell your healthcare provider if you: Have had a severe reaction to RITUXAN or a rituximab product. Have a history of heart problems, irregular heartbeat, or chest pain. Have lung or kidney problems. Have had an infection, currently have an infection, or have a weakened immune system.
How long after a last dose of Rituxan can you give birth?
Females who are able to become pregnant should use effective birth control (contraception) during treatment with RITUXAN and for 12 months after the last dose of RITUXAN.
What to do before a Rituxan infusion?
Your healthcare provider should give you medicines before your infusion of RITUXAN to decrease your chance of having a severe infusion-related reactions. Tell your healthcare provider or get medical help right away if you get any of these symptoms during or after an infusion of RITUXAN: Hives (red itchy welts) or rash.
How long after a Rituxan can you breastfeed?
Are breastfeeding or plan to breastfeed. It is not known if RITUXAN passes into your breast milk. Do not breastfeed during treatment and for at least 6 months after your last dose of RITUXAN. Are taking any medications, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How long after a Rituxan infusion do you have a reaction?
Serious infusion-related reactions can happen during your infusion or within 24 hours after your infusion of RITUXAN.
What does it feel like to have a rituxan?
Severe Skin and Mouth Reactions: Tell your healthcare provider or get medical help right away if you get any of these symptoms at any time during your treatment with RITUXAN: Painful sores or ulcers on your skin, lips, or in your mouth. Blisters.
Where to report RITUXAN side effects?
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch . You may also report side effects to Genentech at (888) 835-2555.
Eligibility
Genentech Access to Care Foundation (Rituxan RA), a patient assistance program provided by Genentech, Inc., offers Rituxan at no cost for up to 90 days to those who are eligible for the program. Eligibility is based off of the following requirements:
Other Tips
If you have any questions please call the Genentech, Inc. program directly.
How long after Rituxan infusion do you have an adverse reaction?
Infusion-Related Reactions: In the Rituxan RA pooled, placebo-controlled studies, incidence of any adverse event within 24 hours of an infusion was 32% vs 23% after the first infusion, and 11% vs 13% after the second infusion in the Rituxan-treated patients and placebo group, respectively. Incidence of acute infusion-related reactions was 27% vs 19% after the first infusion, 9% vs 11% after the second infusion in the Rituxan-treated patients and placebo group, respectively. Serious acute infusion-related reactions were experienced by <1% of patients in either treatment group. Acute infusion-related reactions required dose modification (stopping, slowing, or interruption of the infusion) in 10% and 2% of patients receiving Rituxan or placebo, respectively, after the first course.
What is the best way to diagnose PML?
Consider the diagnosis of PML in any patient presenting with new-onset neurologic manifestations. Evaluation of PML includes, but is not limited to, consultation with a neurologist, brain MRI, and lumbar puncture. Discontinue Rituxan and consider discontinuation or reduction of any concomitant chemotherapy or immunosuppressive therapy in patients who develop PML.
What is the most common infection with Rituxan?
The most common serious infection was pneumonia. Hypogammaglobulinemia: Hypogammaglobulinemia (IgA, IgG, or IgM below the lower limit of normal) has been observed in patients with GPA and MPA treated with Rituxan in GPA/MPA Study 1.
How long does it take for a patient to reactivate HBV?
HBV reactivation has been reported up to 24 months following completion of Rituxan therapy.
How long before a course of Rituxan can you administer non live shots?
For patients treated with Rituxan, physicians should review the patient’s vaccination status and patients should, if possible, be brought up to date with all immunizations in agreement with current immunization guidelines prior to initiating Rituxan and administer non-live vaccines at least 4 weeks prior to a course of Rituxan.
What is the rate of serious infections with Rituxan?
In the experience with Rituxan in 2578 RA patients, the rate of serious infection was 4.31 per 100 patient-years. The most common serious infections (≥0.5%) were pneumonia or lower respiratory tract infections, cellulitis, and urinary tract infections. Fatal serious infections included pneumonia, sepsis, and colitis. Rates of serious infection remain stable in patients receiving subsequent courses.
How long does it take for a PV to test positive for Rituximab?
Using a new ELISA assay, a total of 19/34 (56%) patients with PV treated with the Ritux 3 regimen tested positive for anti-rituximab antibodies by 18 months. The clinical relevance of anti-rituximab antibody formation in Rituxan treated PV patients is unclear.